Drug Profile
ORG 13020
Latest Information Update: 08 Jan 2001
Price :
$50
*
At a glance
- Originator Organon
- Class Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris
Most Recent Events
- 08 Jan 2001 Discontinued-I for Angina pectoris in Europe (Unknown route)
- 14 Mar 2000 No-Development-Reported for Angina pectoris in Europe (Unknown route)
- 23 Nov 1995 New profile